Agilent Technologies (NY: A )
154.16 USD +0.30 (+0.19%) Streaming Delayed Price Updated: 12:39 PM EDT, Aug 4, 2021 Add to My Watchlist
Press releases about Agilent Technologies
Agilent Collaborates With SGS to Release New US EPA Method for the Analysis of Dioxins Using GC/TQ
November 04, 2020
Agilent Technologies Inc. (NYSE: A) announced today a collaboration with SGS has resulted in a new GC/TQ method, the SGS AXYS Method 16130, approved by the US EPA as an alternative method for the...
Agilent to Webcast Fourth-Quarter Fiscal Year 2020 Financial Results Presentation, Sets Date for Virtual Analyst and Investor Meeting
October 29, 2020
Agilent will release fiscal fourth quarter financial results Mon., Nov. 23. and will also host a virtual analyst and investor event Wed., Dec. 9.
Roundhill Acquirers Deep Value ETF Announces Strategy Change
October 26, 2020
From PR Newswire
Agilent Technologies Inc. (NYSE: A) today announced that their 1220, 1260, and 1290 Infinity II LC product families have received the My Green Lab accountability, consistency, and transparency (ACT)...
Agilent Technologies Inc. (NYSE: A) today announced that the Agilent Vaya Raman raw material identity verification system has received a 2020 R&D 100 Award in the Analytical/Test category. The...
Agilent Early Career Professor Award Presented to Carl DeSelm
October 14, 2020
Agilent Technologies Inc. (NYSE: A) today announced that Carl DeSelm, M.D., Ph.D., has received the 2020 Agilent Early Career Professor Award. Dr. DeSelm is an assistant professor of Radiation Oncology...
Agilent Announces the Availability of Objective Decision Support for Pathologists Reviewing Breast Cancer Cases
October 08, 2020
Agilent Technologies Inc. (NYSE: A) today announced the expansion of Visiopharm’s validated image analysis algorithm to incorporate HercepTest™ mAb pharmDx for Dako Omnis, both CE-IVD marked and...
Agilent Expands Line of Innovative Flow Cytometers with the NovoCyte Penteon
September 17, 2020
Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent NovoCyte Penteon, a sensitive flow cytometer with five lasers and up to 30 fluorescence channels. The NovoCyte Penteon...
Agilent Announces Cash Dividend of 18 Cents Per Share
September 16, 2020
Agilent Announces Webcast for Investment Community
September 03, 2020
Agilent Announces SureSelect XT HS2 RNA Reagent Kit, a Library Prep and Target Enrichment Solution for RNA-Seq
September 01, 2020
Agilent Technologies Inc. (NYSE: A) today announced the release of the SureSelect XT HS2 RNA Reagent Kit. This solution features a modular design that enables a simple and parallel approach for both...
Agilent Sets the Standard in Customer Flexibility with Analytical Technology Subscription Model
August 27, 2020
Agilent Technologies Inc. (NYSE: A) today announced its first-ever instrument subscription program, designed to meet the needs of customers with dynamic businesses who want the latest technology backed...
Agilent Reports Third-Quarter Fiscal Year 2020 Financial Results
August 18, 2020
Agilent to Expand State-of-the-Art Manufacturing Capacity for Nucleic Acid-Based Therapeutics
August 18, 2020
MOBILion Closes $35M Series B Financing Round
August 17, 2020
aMoon leads round to expand product portfolio and advance commercial efforts for MOBILion's SLIM technology for biotherapeutics characterization and novel biomarker discovery
From PR Newswire
From EIN Presswire
Agilent Technologies Inc. (NYSE: A) today announced two new mass spectrometry (MS) products: the Agilent 6470B Triple Quadrupole LC/MS (6470 LC/TQ) system, and the Agilent RapidFire 400 system. Both...
Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration has approved the company’s PD-L1 IHC 28-8 pharmDx for expanded use in non-small cell lung cancer (NSCLC).
Agilent Technologies Inc. (NYSE: A) announces that biotech startup Trilogy Sciences has been awarded an Agilent Golden Ticket at LabCentral, a leading biotech innovation hub based in Cambridge,...
Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration has approved the company’s PD-L1 IHC 22C3 pharmDx as a companion diagnostic (CDx) to identify patients...
Agilent Signs Sponsorship Agreement with My Green Lab
April 22, 2020
Agilent Technologies Inc. (NYSE: A) announced today that it has become a top-level sponsor of My Green Lab, a nonprofit organization dedicated to improving the sustainability of scientific research.